Schwabe Pharmaceuticals Acquires MH Pharma, UK

Schwabe Pharmaceuticals Acquires MH Pharma, UK

KARLSRUHE, Germany -- Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany, today announced the acquisition of MH Pharma (UK) Ltd., Marlow, UK. Schwabe Pharmaceuticals, a family owned company founded in 1866, is known as one of the world’s leading companies in the development, manufacturing and marketing of phytomedicines. With the acquisition of the privately held MH Pharma in UK, Schwabe will gain access to the UK market. Schwabe has more than 20 subsidiaries and joint ventures in European countries as well as in the US, Mexico and China. Worldwide sales reached 500 mio € in 2007.

Suggested Articles

LianBio aims to bring much-needed new drugs to China and serve as a partner for U.S. biotechs looking to expand into Asia.

Despite the setback, Fulcrum hailed the data as “very encouraging,” zeroing in on results from a pre-specified sensitivity analysis to make its case.

Bayer has struck a $425 million upfront deal to buy KaNDy in the belief its treatment for menopause-related hot flashes has blockbuster potential.